Public Companies
The MindMed Chronicles: An Interview With Robert Barrow, the CEO of MindMed
The following is a continuation of all our recent MindMed coverage. Over the past few weeks, we published a few conversations with Jake Freeman. Click…

The following is a continuation of all our recent MindMed coverage.
Over the past few weeks, we published a few conversations with Jake Freeman.
Before that, it all began with a two-part interview with Dr. Scott Freeman in August.
A Conversation with the MindMed CEO, Robert Barrow
While we’ve had the pleasure of speaking with Freeman Captial on multiple occasions, we are just as excited to be joined by MindMed’s CEO, Robert Barrow, to help readers better understand their side of the story. This interview with Robert is only the beginning. We fully expect to have him back on again soon.

Stay Tuned for More
We expect to have Rob and others involved in this story back on to continue the narrative. Stick around for more interviews, in-depth analyses, and insights as the story progresses.
Follow the Psychedelic Invest YouTube Channel
As always, please like and subscribe to the Psychedelic Invest YouTube channel.

-
LSD17 hours ago
Cannabis Coalition Forms To Push Biden On Federal Reform: Will It Work This Time?
-
LSD16 hours ago
Study Shows New Mechanism For How Psychedelics Promote Plasticity
-
Public Companies16 hours ago
Nirvana Moves Forward With MedSmart Acquisition
-
Markets & Investing14 hours ago
Psychedelics in Dubai: Therapeutic Role of Psychedelics Explored at Conference in the Arab Region
-
Psilocybin7 hours ago
Oregon Pioneers New Psilocybin Business Models
-
Psilocybin14 hours ago
Enveric Biosciences Announces Two Poster Presentations at the Canadian Chemistry Conference and Exhibition (CSC 2023)
-
Markets & Investing5 hours ago
The 7 Most Promising Penny Stocks to Buy in June